Skip to product information
1 of 4

1

36 capsules*5 boxes/lot. Chinese Herbal. Yangzheng Xiaoji Jiaonang or Yangzheng Xiaoji Capsules apply to primary liver tumor

36 capsules*5 boxes/lot. Chinese Herbal. Yangzheng Xiaoji Jiaonang or Yangzheng Xiaoji Capsules apply to primary liver tumor

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Shipping calculated at checkout.

Yangzheng Xiaoji Jiaonang

Yangzheng Xiaoji Capsules

Yang Zheng Xiao Ji Jiao Nang

Yang Zheng Xiao Ji Capsules

养正消积胶囊

Yangzheng Xiaoji Jiaonang apply to primary liver tumor

ACTIONS
Spleen invigorating and kidney nourishing,removing blood stasis and detoxicating.

INDICATIONS
Applicable to adjuvant treatment of primary liver cancer ( due to spleen and kidney deficiency and blood stasis obstructed),combined with intrahepatic artery intervention plus embolization chemotherapy,to help improve the efficacy of interventional chemotherapy and reduce leukocyte, liver function and detoxic effect hemoglobin,improve the patient's quality of life, improve abdominal pain and bloating, poor appetite,mental fatigue,sorness and weakness of waist and knees,dark urine and diarrhea, pain.

INGREDIENTS
Radix Astragali,Fructus Ligustri Lucidi,Radix Ginseng,Rhizome Curcumae,REISH Ganoderma,Herba Gynostemmati,Rhizoma Atractylodis Macrocephalae,Herba Gynostemmatis,Herba Scutellariae Darbatae,Herba Hedyotidis Diffusae,Poria,Eupolyphaga Seu Steleophaga,Chicken's Gizzard Internal Lining Endothelium Corneum Gigeriae Galli,Herba Duchesneae Indicae,Herba Solani,Herba Artemisiae Capillaris,Radix Cynanchi Paniculati.

PROPERTIES
Hard capsules,brown powder;bitter, puckery.

Spec.
0.39g*36 capsules/box.

USAGE AND DOSAGE
Oral,4 capsules per time,thrice daily;Interventional infusion with intrahepatic arterial embolization plus chemotherapy,the course of treatment is 4 weeks (10 boxes).

ADVERSE REACTION
This product has an inhibitory effect on mouse transplantable tumor S180, liver cancer solid tumor HAC, and Lewis lung cancer; it has an inhibitory effect on human liver cancer SMMC7721 transplanted in nude mice; This product is combined with low-dose chemotherapy drugs show a certain degree of synergistic effect on mouse sarcoma S180 ; promote the proliferation of splenic lymphocytes, NK cell activity and IL-2 production in tumor-bearing mice.it can increase the cyclophosphamide-induced mouse leukopenia decreaded.

CONSTRAINDICATION
Constraindiction during pregnancy,menses and lactation period.

PRECAUTION
After opening the moisture-proof bag, please pay attention to moisture protection.

DRUG INTERACTIONS
If use with the other drugs at the same time may occur drug interactions,details please consult your physician or pharmacist.

VALIDITY
30 months.

STORAGE
Preserve in tightly closed containers,stored in a cool and dry place.

APPROVAL NUMBER
State medical permitment number.Z20040095.

Manufactured
SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD

General Cautions:
Keep away from animals and children.
This product has not been evaluated by the FDA. It is not intended to
diagnose, treat, cure, or prevent any disease.
We highly recommend that you consult with a Traditional Chinese Medical
practitioner or physician before taking any products or if you have any questions regarding your health.

Tips: part of the goods frequent replacement of packaging, such as goods and pictures are not exactly the same, please refer to the goods you receive.

View full details